-
May 10, 2012 Lupin Sales and Operating Profit up 22%
-
April 24, 2012 Lupin To Set Up New Formulations Manufacturing Facility In MIHAN
-
April 19, 2012 Lupin Resumes Sales of Generic Fortamet®
-
March 28, 2012 Lupin launchesGeneric SEROQUEL® Tablets Receives final FDA Approval for its Generic SEROQUEL® Tablets
-
March 3, 2012 Lupin launchesGeneric Geodon® Capsules Receives final FDA Approval for its Generic Geodon® Capsules
-
February 22, 2012 LUPIN announces settlement with SANTARUS and DEPOMED for GLUMETZA Patent Litigation
-
January 30, 2012 Lupin receives Tentative Approval for Generic Glumetza® Extended-Release Tablets
-
January 24, 2012 Strong Growth, Robust Operating Performance
-
December 30, 2011 US FDA clears Lupin’s Mandideep Facility
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications